Darren Denjay Pan MD

PubMed

• Clonal hematopoiesis and inflammation predict hematologic toxicity and secondary myeloid malignancies after BCMA-directed chimeric antigen receptor T cell therapy.
  Zachary M Avigan, Jerrel Catlett, Saoirse Bodnar, Darren Pan, Adolfo Aleman
  Clinical Cancer Research. 2025-08-13
• 1 citations
  Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma.
  Darren Pan, Tarek H Mouhieddine, Tianxiang Sheng, Weijia Fu, Erin Moshier
  Bone Marrow Transplantation. 2025-08-01
• Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review.
  Darren Pan, Anupama Kumar, Jodi J Lipof, Alfred Chung, Jeffrey L Wolf
  Expert Opinion on Investigational Drugs. 2025-05-01

Journal Articles

• Portal and Mesenteric Vein Thrombosis in a Patient with JAK2 V617F Mutation  
  D Pan, R Callahan, Proceedings of UCLA Healthcare, 2016

Books/Book Chapters

• Human Pathobiochemistry 
  Chapter: Acute Myeloid Leukemia: Mutations Blocking Differentiation Lead to Distinct Leukemic Subtypes 
  Page 155 - 168AL Cummings, D Pan, GJ SchillerSpringer2019

Abstracts/Posters

• Outcomes in Multiple Myeloma Patients Progressing on Lenalidomide Maintenance
  L Sanchez, E Moshier, A Coltoff, A Mustafa, D Pan, HJ Cho, S Jagannath, D Madduri, S Parekh, S Richard, J Richter, A Chari, 62nd Annual American Society of Hematology Conference, 11/13/2019
• Race, Socioeconomic Status, and Time to Transplantation in Multiple Myeloma
  D Pan, A Coltoff, U Ozbek, J Lin, S Afshar, A Steinberg, 61st Annual American Society of Hematology Conference, 2018
• Tension Hydropneumothorax: A Rare Consequence of Esophageal Necrosis with Boerhaave Syndrome
  M Lieu, M Layoun, D Pan, W Davis, D Dai, GS Hoo, J Betancourt, Chest Annual Meeting 2016, 2016

Lectures

• Race, Socioeconomic Status, and Time to Transplantation in Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018